Soranib 200 mg Tablet (Sorafenib) treats advanced kidney (renal cell carcinoma), liver (hepatocellular carcinoma), and thyroid (differentiated thyroid carcinoma) cancers. It works by targeting specific proteins that promote tumor growth and blood vessel formation, slowing cancer progression. For detailed medical information, visit Mayo Clinic, Drugs.com, FDA, WebMD, PubMed, Healthline, or WHO.
Key Benefits & Uses
-
Kidney Cancer: Soranib improves progression-free survival in advanced renal cell carcinoma (Mayo Clinic).
-
Liver Cancer: It enhances overall survival in patients with hepatocellular carcinoma (Drugs.com).
-
Thyroid Cancer: Soranib effectively treats differentiated thyroid carcinoma that resists radioactive iodine (FDA).
How to Use
Take one Soranib 200 mg tablet orally twice daily, at least 1 hour before or 2 hours after meals. Swallow it whole; do not crush or chew. If you miss a dose, skip it and take the next dose at the scheduled time. Always consult your healthcare provider for personalized instructions (WebMD, Healthline).
Important Safety Information
-
Pregnancy Category: D (risk to fetus).
-
Interactions: Soranib may interact with certain medications, so inform your doctor about all drugs you take (FDA).
-
Monitoring: Your doctor will monitor liver function and blood counts regularly (PubMed).
-
Surgical Considerations: Stop Soranib before surgery and restart only after wounds heal (WHO).
Common Side Effects
-
Diarrhea, fatigue, nausea, and rash
-
Hand-foot skin reactions and high blood pressure
-
Loss of appetite and weight loss
For a complete list, visit Drugs.com.
Why Choose Soranib 200 mg Tablet
Soranib slows tumor growth and improves survival in patients with advanced cancers. Moreover, its targeted mechanism makes it ideal for those who do not respond to standard therapies (Mayo Clinic).

